{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 111: Dr. Allen Davidoff - Exploring New Therapies to Treat PKD","description":" Dr. Allen Davidoff is the founder and CEO of XORTX Therapeutics, exploring new therapies to treat progressive kidney disease. Educated at The University of Calgary, Allen has 15 years of drug development experience with a focus on clinical and regulatory developmental affairs in the US, Canada, Germany, Denmark, and India. Allen has a broad range of senior management experience in pharmaceutical research and development including involvement in two investigational new drug (\u201cIND\u201d) applications or supplemental IND\u2019s, two phase I studies, seven phase II studies, and one new drug application (NDA). Prior to forming XORTX, Allen was the Chief Scientific Officer, VP Product Development and co-founder of Stem Cell Therapeutics Corp. and Senior Scientist and Head of Pharmacology at Cardiome Pharma Corp.  If you have questions regarding items discussed during this episode or would like more information about Kidney Solutions weekly Support Group, contact Kent at kent.bressler@kidneysolutions.org For more information about Kidney Solutions, visit them at www.kidneysolutions.org Host: Kent Bressler Producer: Jason Nunez ","author_name":"Kent's Kidney Stories","author_url":"http:\/\/kentskidneystories.libsyn.com\/website","html":"